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KEYWORDS 
 Inflammation plays an important role in the pathogenesis of osteoarthritis. 
The study of blood coagulation markers (number of platelets, mean platelet 
volume, fibrinogen, D-dimer, antithrombin ІІІ, C-reactive protein, uric acid) 
was conducted in patients with osteoarthritis in combination with 
hyperuricemia and its ability to increase the risk of negative cardiovascular 
events. This study included 50 patients (40 men and 10 women) suffering 
from osteoarthritis of the knee joints. The average age of patients was 
59.5±3.6 years. Patients were divided into 3 groups: group 1 – patients with 
osteoarthritis; group 2 – patients with osteoarthritis in combination with 
hyperuricemia; group 3 – control group of practically healthy patients. In 
patients with osteoarthritis in combination with hyperuricemia, the above-
described indicators contribute to an increased risk of development of 
negative cardiovascular events. Therefore, there is a need for monitoring 
these indicators in this group of patients. 
osteoarthritis,  
hyperuricemia,  
inflammation,  
blood coagulation, 
cardiovascular events 
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Introduction. Osteoarthritis (OA) is the 
most common form of joint disease [12]. Since 
OA is initiated by mechanical stress on cartilage, 
its progression depends on cellular and 
biochemical factors, including activation of 
chondrocytes and secretion of inflammatory 
mediators [3]. Cytokines such as interleukin (IL)-
1β play an important role in the pathogenesis of 
OA, stimulate the production of 
metalloproteinases and adversely affect the 
survival of chondrocytes [4]. At present, there are 
no reliable biochemical risk markers and the 
prognosis of clinical progression of OA, although 
research in this area is carried out [2, 10]. 
A limited number of studies examined the 
possible relationship between hyperuricemia and 
OA. In high concentrations, uric acid (UA) may 
crystallize as monosodium urate (MSU), 
stimulating NLRP3 inflammasome and 
contributing to the production of IL-1β. Crystal 
aggregates MSU (tophus) can also directly 
damage the cartilage. Perhaps, these or other 
mechanisms, not yet defined, could contribute to 
the development of OA. Thus, even in the 
absence of gout, elevated UA levels can have a 
negative effect on cartilage [4]. 
Formation of secondary changes of cartilage 
tissue during gout in the form of OA is directly 
related to the definition of the role of the 
inflammatory component in the development and 
progression of the degenerative-dystrophic process 
(Li-Yu J et al., 2001). It was shown that MSU 
crystals that are presented in the synovial fluid 
stimulate the synthesis of pro-inflammatory 
cytokines monocytes and synoviocytes cytokines 
such as FNP-α, IL-6, IL-8. The latter, in turn, 
causes the development of chronic synovitis, 
inflammation of periarticular tissues and contributes 
to the gradual destruction of cartilage (Inokushi T et 
al., 2006). Increased synthesis of IL stimulates 
catabolism of the collagen matrix, enhances the 
synthesis of enzymes and degrades cartilaginous 
tissue, which leads to the development of secondary 
OA (Inokushi T et al., 2006). 
It is believed that one of the key 
mechanisms of inflammation in OA is the 
activation of thrombin via a plasminogen 
activator inhibitor (PAI-1). It is known that 
thrombin takes part in the activation of platelets 
and endothelial cells, stimulates the deposition of 
fibrin, which promotes adhesion and leukocyte 
migration to the inflammation zone [1]. 
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Another component of the pathological 
process is the specific proteolytic enzymes. In the 
destruction of joints in OA plasmin directly or 
indirectly destroys the extracellular matrix [6] 
and activates matrix metalloproteinases [9], 
which cause carotid erosion with OA [6]. 
Actual questions remain the definition of 
certain markers to characterize the course and 
severity of OA, as well as the study of the 
relationship between OA and cardiovascular 
diseases, their common risk factors and the main 
pathogenetic mechanisms. The optimal monitoring 
strategy for such patients in the guidelines and 
recommendation is not disclosed to the end. 
The aim of the study was to evaluate the 
markers of blood coagulation in patients with 
OA, which contribute to the risk of developing 
negative cardiovascular events. 
Methods. This study included 50 patients 
(40 men and 10 women) suffering from OA knee 
joints. The average age of patients was 
59.5±3.6 years. The duration of the disease on the 
OA was 7.8±1.7 years. Diagnosis of OA was 
established according to the clinical and 
radiological criterias of the American College of 
Rheumatology. Patients were divided into 
3 groups: group 1 – patients with OA; group 2 –
patients with OA in combination with 
hyperuricemia; group 3 – control group of 
practically healthy patients. It was conducted a 
study of laboratory parameters: the number of 
platelets, the mean platelet volume (MPV), the 
level of fibrinogen, D-dimer, antithrombin III 
(ATIII), C-reactive protein (CRP), UA. Statistical 
processing of the study results was conducted 
with the using of a package STATISTICA 6.1. 
Results. The arterial hypertension and 
coronary heart disease are most often discovered 
in patients with OA. It is important to note that 
the increased prevalence of cardiovascular 
diseases in OA can affect the options and 
outcomes of patients‘ treatment. In the 2nd group 
of patients, more than in the 1st group, high 
prevalence of diabetes mellitus, 
hypercholesterolemia and obesity were recorded 
in comparison with the control group. According 
to the study, it was found that the lowest MPV 
values were recorded in the second group of 
patients compared to the control group. 
Correlation between MPV and CRP was found, 
which testifies to association of MPV with 
inflammatory and cardiovascular diseases. 
The effects of platelets that play an 
important role in inflammation and thrombogenic 
situations are still unknown. It can be assumed 
that the platelets release a large number of local 
inflammatory cytokines in the inflammatory area. 
In addition, it should be noted that due to isolated 
cytokines they cause activation of other 
inflammatory cells [2]. Thrombocyte 
degranulation results in the release of various 
growth factors and chemoattractants that affect 
bone metabolism [8]. 
The production of cytokines and the 
development of inflammatory process in OA, 
contribute to vascular damage [6] and the 
development of atherosclerosis, which underlie 
many cardiovascular diseases. According to 
Wang N et al., bone ischemia reduces trophic 
cartilage and induces multiple bone infarctions. 
This effect of bone ischemia is one of the 
potential explanations of the relationship between 
OA and cardiovascular disease [11]. 
In OA in combination with hyperuricemia, 
loss of chondrocytes occurs, pericellular uric acid 
increases, which promotes the local formation of 
crystals at the microscopic level [4]. The latter 
may, to a certain extent, be reflected in the 
process of blood clotting. OA is more common 
among patients with hyperuricemia. It was in 
these patients that the increased level of 
fibrinogen was determined by 30%, D-dimer by 
18%, and decreased level of AT III by 20%. The 
level of blood coagulation factors was also 
affected by the presence of obesity and age. The 
accumulation of fibrinogen increases the risk of 
negative cardiovascular events. Since 
hyperuricemia, in some way, contributes to the 
severity of OA, its effect on the activity of blood 
coagulation factors is not excluded. 
It was found a correlation between the 
level of CRP and UA; between the level of 
fibrinogen and CRP (r=0.31, p<0.01), indicating 
a negative influence of the inflammatory process 
and hyperuricemia on the development of 
cardiovascular events. 
Conclusion. In patients with OA in 
combination with hyperuricemia, indicators such 
as the MPV, fibrinogen, AY III, CRP and UA, 
increase the risk of developing negative 
cardiovascular events. Therefore, there is a need 
of monitoring these indicators in this group of 
patients. 
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